Your institution may have access to this item. Find your institution then sign in to continue.

Title: A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.
Authors: Lonial, Sagar; Van de Donk, Niels; Popat, Rakesh; Zonder, Jeffrey A.; Minnema, Monique; Larsen, Jeremy T.; Nguyen, Tuong Vi; Chen, Min S.; Bensmaine, Amine; Peluso, Teresa; Sonneveld, Pieter
Publication: Clinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pe52
ISSN: 2152-2650
Publication type: Academic Journal
DOI: 10.1016/j.clml.2019.09.080

We found a match

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.